当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 现金流量表

博雅生物

(300294)

  

流通市值:86.58亿  总市值:86.58亿
流通股本:5.04亿   总股本:5.04亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金341,454,956.091,795,878,275.021,326,624,834.33871,330,951.42
  收到其他与经营活动有关的现金7,656,958.9860,308,940.0236,381,215.2429,841,503.28
  经营活动现金流入小计349,111,915.071,856,187,215.041,363,006,049.57901,172,454.7
  购买商品、接受劳务支付的现金195,691,241.35768,172,040.87556,386,378.2362,939,888.99
  支付给职工以及为职工支付的现金135,041,340.57368,449,075.26290,389,236.5204,998,492.12
  支付的各项税费50,932,713.63183,180,958.57165,421,983.06106,241,298.89
  支付其他与经营活动有关的现金94,675,986.76475,222,452.76324,697,809.93220,046,405.38
  经营活动现金流出小计476,341,282.311,795,024,527.461,336,895,407.69894,226,085.38
  经营活动产生的现金流量净额-127,229,367.2461,162,687.5826,110,641.886,946,369.32
二、投资活动产生的现金流量:
  收回投资收到的现金2,261,091,453.314,975,020,107.174,645,065,066.712,232,899,001.82
  取得投资收益收到的现金24,765,666.0155,522,406.7653,758,930.8129,224,495.91
  处置固定资产、无形资产和其他长期资产收回的现金净额210,148.123,061,389.562,098,306.711,706,908.52
  处置子公司及其他营业单位收到的现金净额-193,790,119.76158,160,797.81-
  投资活动现金流入小计2,286,067,267.445,227,394,023.254,859,083,102.042,263,830,406.25
  购建固定资产、无形资产和其他长期资产支付的现金187,543,430.76535,308,549.07412,844,043.06281,267,931.04
  投资支付的现金2,281,000,0005,373,000,0004,810,000,0002,200,000,000
  投资活动现金流出小计2,468,543,430.765,908,308,549.075,222,844,043.062,481,267,931.04
  投资活动产生的现金流量净额-182,476,163.32-680,914,525.82-363,760,941.02-217,437,524.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,000,0001,000,000-
  其中:子公司吸收少数股东投资收到的现金-1,000,0001,000,000-
  取得借款收到的现金11,230,00047,035,988.71,162,988.7-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计11,230,00048,035,988.72,162,988.7-
  分配股利、利润或偿付利息支付的现金287,796.19156,396,539.61156,317,254.1580,679,798.08
  支付其他与筹资活动有关的现金4,137,061.6846,708,824.5644,955,158.663,476,007.11
  筹资活动现金流出小计4,424,857.87203,105,364.17201,272,412.8184,155,805.19
  筹资活动产生的现金流量净额6,805,142.13-155,069,375.47-199,109,424.11-84,155,805.19
四、汇率变动对现金及现金等价物的影响-104,238.48-133,997.22-57,739.96-7,950.92
五、现金及现金等价物净增加额-303,004,626.91-774,955,210.93-536,817,463.21-294,654,911.58
  加:期初现金及现金等价物余额523,616,179.041,298,571,389.971,298,571,389.971,298,571,389.97
  期末现金及现金等价物余额220,611,552.13523,616,179.04761,753,926.761,003,916,478.39
补充资料:
  净利润-112,638,772.02-225,409,614.24
  资产减值准备-316,529,570.79-9,662,728.44
  固定资产和投资性房地产折旧-96,960,872.94-51,790,115.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-96,910,547.58-51,790,115.9
    投资性房地产折旧-50,325.36--
  无形资产摊销-49,621,357.38-24,750,166.98
  长期待摊费用摊销-13,040,303.6-6,133,291.26
  递延收益摊销-5,880,718.28--
  处置固定资产、无形资产和其他长期资产的损失--5,095,324.42--5,280,299.53
  固定资产报废损失-1,343,862.03-263,920.03
  公允价值变动损失--59,977,597.95--37,004,306.86
  财务费用--14,541,893.43-454,554.7
  投资损失--23,806,314.16--2,529,169.37
  递延所得税--78,017,575.79-6,722,503.98
  其中:递延所得税资产减少--9,695,384.51--3,592,418.83
    递延所得税负债增加--68,322,191.28-10,314,922.81
  存货的减少--12,597,837.43--23,694,524
  经营性应收项目的减少--471,723,170.76--239,741,023.85
  经营性应付项目的增加-102,135,210.93--12,013,108.27
  不涉及现金收支的投资和筹资活动金额其他项目-11,095,417.78--
  现金的期末余额-523,616,179.04-1,003,916,478.39
  减:现金的期初余额-1,298,571,389.97-1,298,571,389.97
  现金及现金等价物的净增加额--774,955,210.93--294,654,911.58
公告日期2026-04-252026-03-212025-10-282025-08-23
审计意见(境内)标准无保留意见
TOP↑